studi
human
respiratori
syncyti
viru
pathogenesi
immun
hamper
exquisit
host
specif
difficulti
encount
adapt
viru
murin
host
reason
obstacl
well
understood
appear
reflect
least
part
inabl
viru
block
interferon
respons
human
host
review
address
issu
encount
mous
model
respiratori
syncyti
viru
infect
describ
advantag
disadvantag
altern
model
system
respiratori
syncyti
viru
rsv
member
paramyxoviru
famili
remain
major
clinic
problem
effect
vaccin
treatment
ubiquit
respiratori
pathogen
infect
human
age
common
caus
lower
respiratori
tract
infect
infant
young
children
sever
diseas
afflict
infant
experienc
primari
infect
rsv
infect
older
children
adult
gener
produc
rel
mild
ill
limit
upper
respiratori
tract
infect
caus
fatal
pneumonia
immunocompromis
host
cohort
includ
young
infant
immatur
immun
system
fragil
elderli
interest
capac
viru
frequent
reinfect
human
host
phenomenon
well
understood
unlik
acut
respiratori
viru
infect
abil
rsv
reinfect
human
patient
appear
due
rapid
viru
evolut
trait
common
mani
rna
virus
although
publish
evid
suggest
circul
viral
clade
chang
respect
predomin
given
popul
evid
progress
viral
evolut
result
emerg
new
strain
observ
interest
given
viru
known
anim
reservoir
sourc
inevit
yearli
epidem
unclear
exquisit
specif
rsv
human
host
made
challeng
develop
small
anim
model
rsv
pathogenesi
therefor
difficult
understand
basi
rel
ineffect
human
immun
respons
infect
dilemma
major
hurdl
vaccin
develop
unsuccess
despit
half
centuri
intens
research
cormier
et
al
estim
publish
rsv
studi
carri
mice
speci
well
character
genet
host
immunolog
techniqu
reagent
avail
mani
import
studi
carri
mous
model
rsv
infect
recent
review
openshaw
limit
model
leav
open
question
abil
translat
inform
gain
studi
clinic
practic
major
issu
anim
model
develop
rel
resist
rodent
speci
human
rsv
infect
although
commonli
use
balbc
mous
shown
among
suscept
mous
strain
inocul
mice
larg
dose
viru
produc
minim
microscop
diseas
total
viral
yield
order
viru
input
high
degre
rsv
adapt
natur
host
homo
sapien
present
complic
challeng
develop
interpret
anim
model
even
phylogenet
close
match
host
nonhuman
primat
rsv
replic
pathogenesi
poorli
reflect
human
rsv
infect
two
approach
toward
improv
mous
model
contempl
adapt
hrsv
nonhuman
host
use
relat
cognat
virushost
pair
first
approach
exemplifi
adapt
multipl
human
pathogen
mice
serial
passag
exampl
influenza
viru
sar
ebolaviru
adult
mice
resist
infect
strain
ebolaviru
isol
human
though
suckl
mice
suscept
bray
et
al
passag
viru
success
older
mice
recov
six
cycl
mouseadapt
ebolaviru
key
mutat
account
virul
mice
determin
mutat
confer
resist
interferon
respons
attempt
adapt
hrsv
mous
success
low
ratio
progeni
inoculum
viru
vivo
passag
repres
insurmount
hurdl
approach
passag
viru
cultur
mous
cell
hundr
cycl
despit
accumul
genotyp
phenotyp
ie
plaqu
morpholog
chang
seen
appar
shift
abil
passag
viru
replic
mous
unpublish
data
mice
lack
signal
transduc
activ
transcript
therefor
interferon
respons
fact
suscept
hrsv
see
figur
even
model
host
describ
best
semipermiss
rsv
replic
ratio
progeni
inoculum
still
thu
like
mismatch
hrsv
innat
immun
counterdefens
correspond
molecular
target
mice
independ
pathway
rsv
gene
product
associ
inhibit
interferon
respons
protein
implic
acceler
degrad
human
cell
critic
respons
type
type
iii
interferon
inactiv
rigi
essenti
induct
type
type
iii
interferon
extent
viral
product
tune
natur
host
best
demonstr
bossert
conzelmann
construct
rhabdovirus
either
human
bovin
rsv
found
resist
result
recombin
virus
type
interferon
host
specif
even
close
relat
virus
permiss
rodent
model
rsv
diseas
speci
use
increas
frequenc
test
rsv
vaccin
therapeut
cotton
rat
sigmodon
hispidu
recent
review
detail
boukhvalova
et
al
addit
increas
viru
replic
respiratori
tract
infect
cotton
rat
close
resembl
seen
human
subject
diffus
infect
nasal
mucosa
replic
limit
bronchiolar
rather
alveolar
mucosa
seen
mous
lung
see
figur
also
similar
human
patient
cotton
rat
suscept
reinfect
upper
airway
begin
month
primari
infect
unlik
new
world
rodent
guinea
pig
also
use
rsv
studi
cotton
rat
avail
inbr
strain
grow
number
reagent
avail
studi
cytokin
chemokin
speci
altern
approach
anim
model
develop
explor
util
relat
cognat
virushost
pair
pair
involv
rodent
identifi
date
pneumonia
viru
mice
pvm
system
similar
infect
human
hrsva
small
inoculum
produc
order
magnitud
progeni
substanti
pathogenesi
one
sever
drawback
system
howev
remot
relationship
pvm
hrsv
see
figur
render
extrapol
distantli
relat
gene
product
mechan
tenuou
pneumoviru
close
relat
hrsv
bovin
rsv
brsv
first
isol
calv
estim
similar
nucleotid
level
elvand
et
al
rang
studi
three
hrsv
strain
exhibit
genet
similar
approxim
bovin
rsv
natur
occur
infect
calv
infect
subclin
involv
upper
respiratori
tract
upper
lower
respiratori
tree
clinic
sign
includ
tachypnea
oculonas
discharg
anorexia
reduc
activ
fever
sign
coincid
brsv
replic
detect
earli
day
continu
day
postinfect
like
hrsv
brsvassoci
diseas
sever
young
calv
less
month
age
infect
occur
even
presenc
matern
antibodi
estim
calv
seroconvert
age
month
hrsv
children
reinfect
calv
common
also
like
hrsv
season
period
seen
brsv
temper
climat
common
occurr
infect
fall
winter
month
bovin
respiratori
tract
provid
excel
model
system
studi
human
respiratori
diseas
upper
respiratori
tract
bovin
palatin
nasopharyng
tonsil
similar
human
tonsil
tonsil
present
rodent
speci
bovin
human
trachea
line
ciliat
pseudostratifi
columnar
epithelium
wherea
mice
major
tracheal
surfac
popul
noncili
epitheli
cell
airway
submucos
gland
common
human
rumin
wherea
mous
suggest
rel
larg
airway
lumen
lack
mucos
gland
mice
may
result
littl
compromis
lung
function
result
inflammatori
process
wherea
would
case
larger
anim
includ
human
experiment
infect
calv
brsv
reproduc
clinic
sign
seen
field
case
sign
observ
vari
sever
like
depend
variabl
rout
inocul
dose
number
inocul
age
calv
challeng
use
brsv
aerosol
challeng
model
adapt
describ
woolum
et
al
calf
receiv
ml
challeng
inoculum
contain
approxim
ml
brsv
nebul
period
min
follow
infect
brsv
replic
upper
respiratori
tract
epitheli
cell
spread
lower
airway
peak
viral
titer
occur
day
follow
rapid
declin
shed
detect
day
follow
challeng
signific
microscop
lesion
appar
bronchiol
fill
neutrophil
cell
debri
surround
inflammatori
cell
expans
interstiti
space
edema
fluid
macrophag
lymphocyt
human
subject
viral
antigen
stain
primarili
restrict
cell
line
bronchiol
see
figur
adapt
immun
respons
requir
control
clearanc
establish
rsv
infect
follow
infect
human
cattl
mount
virusspecif
antibodi
cell
respons
howev
respons
weak
transient
speci
continu
reinfect
throughout
life
cell
respons
direct
epitop
within
sever
brsv
protein
includ
n
f
g
calv
infect
brsv
develop
mix
cytokin
respons
favor
develop
immun
respons
follow
infect
studi
cell
lymph
fluid
brsv
infect
calv
reveal
enhanc
product
serum
tissu
earli
day
post
infect
increas
serum
level
virusspecif
ige
indic
establish
respons
prospect
human
studi
suggest
sever
rsv
diseas
infanc
may
predispos
act
marker
develop
asthma
later
life
interestingli
brsv
infect
calv
also
shown
predispos
allerg
sensit
sever
rsv
infect
human
infant
associ
signific
influx
cell
airway
calv
infect
brsv
exhibit
similar
increas
cell
lung
trachea
nasopharynx
hla
class
restrict
respons
human
patient
primarili
direct
f
n
protein
wherea
bovin
cell
target
f
n
g
protein
brsv
interestingli
gspecif
cell
readili
detect
cattl
demonstr
human
subject
humor
immun
also
play
import
role
protect
rsv
infect
complet
effect
matern
antibodi
may
provid
level
protect
sever
rsv
infect
human
infant
calv
howev
presenc
also
describ
suppress
develop
antibodi
cell
respons
acut
infect
addit
sacco
choic
anim
model
must
base
mani
factor
includ
expens
avail
method
reagent
nonetheless
consider
addit
factor
viru
suscept
viral
adapt
host
immun
defens
also
determin
use
given
model
understand
mechan
viral
pathogenesi
immun
man
mous
model
allow
us
use
power
genet
approach
inabl
adapt
viru
growth
speci
leav
open
question
relev
mous
studi
human
diseas
cotton
rat
suscept
provid
model
upper
lower
airway
infect
rel
tool
current
avail
mechanist
studi
speci
despit
practic
difficulti
work
larg
anim
mani
reason
suggest
greater
focu
understand
brsv
pathogenesi
immun
cattl
yield
inform
translat
improv
strategi
hrsv
treatment
vaccin
studi
rodent
foremost
inabl
adapt
hrsv
rodent
model
coupl
close
relationship
hrsv
brsv
similar
viral
pathogenesi
dynam
viru
spread
appar
block
develop
effect
immun
human
bovin
system
exquisit
host
specif
pathogen
overcom
may
wise
studi
basi
adapt
use
brsv
natur
host
hrsv
effect
brsv
vaccin
yet
achiev
despit
major
econom
impact
viru
longer
lifespan
cattl
rel
rodent
possibl
studi
memori
b
cell
popul
respons
rsv
antigen
year
rather
week
effect
experiment
vaccin
variabl
lifetim
mice
uppermost
airway
resist
hrsv
infect
photomicrograph
taken
show
nasal
septum
four
day
intranas
deliveri
hrsv
wild
type
wt
mice
anim
lack
receptor
chain
transcript
factor
signal
transduc
activ
transcript
presenc
viral
protein
demonstr
immunohistochemistri
rsv
infect
cell
stain
red
wt
mice
rare
cell
infect
infect
appear
spread
adjac
cell
nasal
respiratori
mucosa
anim
rel
permiss
suggest
ifn
signal
restrict
viru
spread
mous
ifnar
mice
respond
type
ifn
recent
discov
type
iii
ifn
also
play
role
antivir
protect
depend
cotton
rat
nasal
caviti
suscept
infect
hrsv
diffus
immunostain
nasal
mucosa
red
shown
left
hand
panel
human
patient
lower
airway
infect
cotton
rat
involv
columnar
epithelium
line
bronchiol
seen
central
right
hand
panel
distinct
infect
mous
model
primarili
alveolar
line
cell
infect
hrsv
lung
section
examin
immunohistochemistri
curr
opin
virol
author
manuscript
avail
pmc
august
